ADVFN Logo

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers
TC BioPharm Holdings PLC

TC BioPharm Holdings PLC (TCBP)

1.31
-0.12
(-8.39%)
At close: March 28 04:00PM
1.3194
-0.1106
( -7.73% )
After Hours: 07:00PM

Unlock more advanced trading tools

Join ADVFN today

Key stats and details

Current Price
1.3194
Bid
1.29
Ask
1.32
Volume
413,305
1.30 Day's Range 1.49
0.00 52 Week Range 0.00
Market Cap
Previous Close
1.43
Open
1.43
Last Trade
60
@
1.3195
Last Trade Time
19:06:02
Financial Volume
$ 561,021
VWAP
1.3574
Average Volume (3m)
-
Shares Outstanding
950,000
Dividend Yield
-
PE Ratio
-0.89
Earnings Per Share (EPS)
-1.46
Revenue
3.85M
Net Profit
-1.39M

About TC BioPharm Holdings PLC

TC BioPharm (Holdings) PLC is a clinical-stage biopharmaceutical company focused on developing novel immunotherapy products that are based on its proprietary allogeneic gamma delta T (abbreviated as GD-T) cell platform. TC BioPharm (Holdings) PLC is a clinical-stage biopharmaceutical company focused on developing novel immunotherapy products that are based on its proprietary allogeneic gamma delta T (abbreviated as GD-T) cell platform.

Sector
Coml Physical, Biologcl Resh
Industry
Coml Physical, Biologcl Resh
Headquarters
Scotland, Gbr
Founded
1970
TC BioPharm Holdings PLC is listed in the Coml Physical, Biologcl Resh sector of the NASDAQ with ticker TCBP. The last closing price for TC BioPharm was $1.43. Over the last year, TC BioPharm shares have traded in a share price range of $ 0.00 to $ 0.00.

TC BioPharm currently has 950,000 shares outstanding. The market capitalization of TC BioPharm is $1.24 million. TC BioPharm has a price to earnings ratio (PE ratio) of -0.89.

TCBP Latest News

TCBP Adjourns General Meeting Until a Later Date

TCBP Adjourns General Meeting Until a Later Date PR Newswire EDINBURGH, Scotland, March 19, 2024 EDINBURGH, Scotland, March 19, 2024 /PRNewswire/ -- TC BioPharm (Holdings) PLC ("TC BioPharm" or...

TCBP Announces Exercise of Series D Warrants For Cash

TCBP Announces Exercise of Series D Warrants For Cash PR Newswire EDINBURGH, Scotland, March 18, 2024 โ€ขย  Company receives gross proceeds of $1.26 M from transaction EDINBURGH, Scotland, March 18...

Form 8-K - Current report

false 0001872812 0001872812 2024-02-29 2024-02-29 0001872812 TCBP:AmericanDepositarySharesEachRepresentingMember 2024-02-29 2024-02-29...

Bryan Kobel, CEO of TCBP, Appears on Nationally Syndicated "The Big Biz Show"

Bryan Kobel, CEO of TCBP, Appears on Nationally Syndicated "The Big Biz Show" PR Newswire EDINBURGH, Scotland, March 1, 2024 EDINBURGH, Scotland, March 1, 2024 /PRNewswire/ -- TC...

/C O R R E C T I O N -- TC BioPharm/

/C O R R E C T I O N -- TC BioPharm/ PR Newswire EDINBURGH, Scotland, Feb. 27, 2024 In the news release, TCBP Announces Shareholder Update Call on March 5th 2024, issued 27-Feb-2024 by TC...

TCBP Announces Shareholder Update Call on March 5th 2024

TCBP Announces Shareholder Update Call on March 5th 2024 PR Newswire EDINBURGH, Scotland, Feb. 27, 2024 EDINBURGH, Scotland, Feb. 27, 2024 /PRNewswire/ -- TC BioPharm (Holdings) PLC ("TC...

TCBP Announces MHRA Acceptance of Amendment for ACHIEVE UK Trial

TCBP Announces MHRA Acceptance of Amendment for ACHIEVE UK Trial PR Newswire EDINBURGH, Scotland, Feb. 22, 2024 Increases dose level in line with Cohort 2 in INDChanges from "in patient" to "out...

Form DEF 14A - Other definitive proxy statements

      UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549   SCHEDULE 14A Information Proxy Statement Pursuant to Section 14(a) of the Securities...

PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
10000000DR
40000000DR
120000000DR
260000000DR
520000000DR
1560000000DR
2600000000DR

Market Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
QLIQilian International Holding Group Ltd
$ 1.05
(52.20%)
2.84M
SBFMSunshine Biopharma Inc
$ 0.0821
(35.70%)
25.96M
GRTXGalera Therapeutics Inc
$ 0.1731
(23.64%)
1.26M
MEDPMedpace Holdings Inc
$ 480.00
(18.77%)
1.41k
JSPRWJasper Therapeutics Inc
$ 0.2147
(17.97%)
600
XTKGX3 Holdings Company Ltd
$ 0.646
(-34.75%)
1.32M
VVOSVivos Therapeutics Inc
$ 3.79
(-21.53%)
82.06k
NDRAENDRA Life Sciences Inc
$ 0.46
(-20.69%)
140.76k
KYCHKeyarch Acquisition Corporation
$ 10.00
(-18.70%)
9.97k
NVVENuvve Holding Corporation
$ 0.90
(-18.18%)
137.27k
SBFMSunshine Biopharma Inc
$ 0.0821
(35.70%)
25.96M
CRKNCrown Electrokinetics Corporation
$ 0.0606
(1.17%)
7.24M
AAPLApple Inc
$ 171.30
(-0.10%)
3.57M
JAGXJaguar Health Inc
$ 0.0872
(-3.00%)
3.5M
CISSC3is Inc
$ 0.0341
(-2.01%)
3.26M

TCBP Discussion

View Posts
Awl416 Awl416 2 weeks ago
Smells in here given that volume of 130m
๐Ÿ‘๏ธ0
Invest-in-America Invest-in-America 2 weeks ago
TCBP: But, nobody interested --- whatever works.
๐Ÿ‘๏ธ0
surf1944 surf1944 1 month ago
https://stockcharts.com/h-sc/ui?s=tcbp&p=D&yr=0&mn=6&dy=0&id=p38090673899

https://www.barchart.com/stocks/quotes/tcbp/technical-chart?plot=CANDLE&volume=total&data=DO&density=M&pricesOn=1&asPctChange=0&logscale=1&indicators=BBANDS(20,2);SMA(13);PTP(50);ADX(14);SMA(50);SMACD(12,26,9);RSI(14,100);ACCUM;STOSL(14,3)&sym=CNNA&grid=1&height=500&studyheight=100

https://www.barchart.com/stocks/quotes/tcbp/opinion

https://finance.yahoo.com/quote/tcbp/

Chart bounce candidate!
๐Ÿ‘๏ธ0
Monksdream Monksdream 1 month ago
TCBP new 52 week low
๐Ÿ‘๏ธ0
EyalCap EyalCap 1 month ago
$TCBP The acceptance of TC BioPharmโ€™s amendment by the MHRA for the ACHIEVE UK trial can be seen as a bullish signal for several reasons:

1. Enhanced Trial Flexibility: The ability to increase the dose level for TCB008 and shift to an outpatient procedure may improve the trialโ€™s efficiency and patient experience. This flexibility could potentially lead to better trial outcomes and patient adherence.
2. Operational Efficiency: Reducing the need for overnight hospital stays for patients after dosing not only improves the quality of life for participants but also eases the burden on clinical sites. This operational efficiency can accelerate the trialโ€™s progress.
3. Positive Regulatory Feedback: Gaining regulatory acceptance for amendments suggests a positive interaction between TC BioPharm and regulatory bodies, indicating that the company is responsive and adaptable to both regulatory requirements and clinical insights.
4. Potential Impact on FDA Trial: The amendments align with the dosing levels of the Investigational New Drug (IND) application for the second cohort, which might streamline the process for the FDA trial. This proactive approach to aligning international trial standards may facilitate smoother regulatory negotiations and trial implementations in multiple jurisdictions.
5. Innovative Treatment Potential: The focus on TCB008 and its application in treating Acute Myeloid Leukemia (AML) underscores TC BioPharmโ€™s commitment to developing innovative cancer treatments. Success in these trials could position the company as a leader in gamma-delta T cell therapies, potentially opening up significant market opportunities.
๐Ÿ‘๏ธ0
elks elks 1 month ago
Chart bottom looks like.
๐Ÿ‘๏ธ0
glenn1919 glenn1919 2 months ago
TCBP..................................https://stockcharts.com/h-sc/ui?s=TCBP&p=W&b=5&g=0&id=p86431144783
๐Ÿ‘๏ธ0
elks elks 2 months ago
I want double digits
๐Ÿ‘๏ธ0
londonohoyos londonohoyos 2 months ago
How high might it go
๐Ÿ‘๏ธ0
elks elks 2 months ago
In.
๐Ÿ‘๏ธ0
TheFinalCD TheFinalCD 2 months ago
tcbp $2 break
๐Ÿ‘๏ธ0
tw0122 tw0122 2 months ago
Looking better $1.80s premarket and warrants should be out of way next push.


"Series E Warrants") to purchase up to 1,750,000 of its ADSs at a public offering price of $2.00 per ADS (or pre-funded warrant in lieu thereof) and associated Series
๐Ÿ‘๏ธ0
Monksdream Monksdream 2 months ago
Wash trade du jour in the making
๐Ÿ‘๏ธ0
TheFinalCD TheFinalCD 2 months ago
CORRECTION: I found out he was trying to get Dave Portnoys attention, thats why he kept tagging him in his posts

not that Dave from BAR STOOLS has anything to do with or even a shareholder of TCBP
๐Ÿ‘๏ธ0
TheFinalCD TheFinalCD 2 months ago
https://stocktwits.com/ProfessorDman1/message/560859418
๐Ÿ‘๏ธ0
TheFinalCD TheFinalCD 2 months ago
this guy is claiming the Dave Portnoy gave this pick @ .90?

Im still trying to figure it out

Yesterday .90s https://t.co/u5JxgsgSwo pic.twitter.com/VzxPdy2Cdc— professor D๐Ÿ”ฅman (@professorDman1) February 8, 2024

$TCBP 1.49 Dave @stoolpresidente @Stocktwits we gonna see double digits run— professor D๐Ÿ”ฅman (@professorDman1) February 9, 2024

Dave @stoolpresidente gave you this yesterday .90s $TCBP we are gonna see 5-7 run then 10-20+ run maybe $50+ like what $HOLO did > with right volume n news which is due ! This is billion dollar market industryโ€ฆ pic.twitter.com/xCgbVxKVu8— professor D๐Ÿ”ฅman (@professorDman1) February 8, 2024
๐Ÿ‘๏ธ0
londonohoyos londonohoyos 2 months ago
When is it going to stop going down
๐Ÿ‘๏ธ0
Monksdream Monksdream 2 months ago
TCBP new 52 week low
๐Ÿ‘๏ธ0
Monksdream Monksdream 2 months ago
TCBP new 52 week low
๐Ÿ‘๏ธ0
Monksdream Monksdream 2 months ago
TCBP new 52 week low
๐Ÿ‘๏ธ0
surf1944 surf1944 2 months ago
https://stockcharts.com/h-sc/ui?s=tcbp&p=D&yr=0&mn=6&dy=0&id=p38090673899

https://www.barchart.com/stocks/quotes/tcbp/technical-chart?plot=CANDLE&volume=total&data=DO&density=M&pricesOn=1&asPctChange=0&logscale=1&indicators=BBANDS(20,2);SMA(13);PTP(50);ADX(14);SMA(50);SMACD(12,26,9);RSI(14,100);ACCUM;STOSL(14,3)&sym=CNNA&grid=1&height=500&studyheight=100

https://www.barchart.com/stocks/quotes/tcbp/opinion

https://finance.yahoo.com/quote/tcbp/

Looking for a bottom in TCBP!
๐Ÿ‘๏ธ0
Monksdream Monksdream 2 months ago
TCBP new 52 week low
๐Ÿ‘๏ธ0
glenn1919 glenn1919 2 months ago
TCBP............................https://stockcharts.com/h-sc/ui?s=TCBP&p=W&b=5&g=0&id=p86431144783
๐Ÿ‘๏ธ0
microcapbiotech microcapbiotech 3 months ago
Sold later in afternoon at $3.16. Will wait unti after the coming RS.
๐Ÿ‘๏ธ0
microcapbiotech microcapbiotech 3 months ago
Started a position today (1-2-24) in TCBP at $3.08. With a market cap of just 2.4 million and only 752 thousand shares outstanding, figure it is worth a shot.
๐Ÿ‘๏ธ0
TheFinalCD TheFinalCD 3 months ago
1/18/2023, 1:55:43 PMPre-funded warrants likely all exercised and sold already. Current float closer to 2m.
https://dilutiontracker.com/app/search/TCBP?a=dbb88c
๐Ÿ‘๏ธ0
Disquisition Disquisition 3 months ago
OFFERING!!!! Baw haw haw haw
๐Ÿ‘๏ธ0
Disquisition Disquisition 3 months ago
SUSTAINED DUMPING
๐Ÿ‘๏ธ0
starkd748 starkd748 4 months ago
They dumped very hard on news
๐Ÿ‘๏ธ0
starkd748 starkd748 4 months ago
Dumping shares on news wow... Watching for mow
๐Ÿ‘๏ธ0
Sly1969 Sly1969 4 months ago
Yes they are. No doubts here. IND application approval decision was due yesterday. News any day. Most likely Monday morning.
๐Ÿ‘๏ธ0
TKgreen TKgreen 4 months ago
Their gonna miss a HUGE RUN!!
๐Ÿ‘๏ธ0
Awl416 Awl416 4 months ago
Pm volume
๐Ÿ‘๏ธ0
Sly1969 Sly1969 4 months ago
I see this board still sleeping on TCBP with IND application approval pending for AML patients who are refractory/relapse .
๐Ÿ‘๏ธ0
TKgreen TKgreen 4 months ago
https://ir.tcbiopharm.com/news/press-releases/detail/67/tc-biopharm-announces-successful-completion-of-safety
👍️ 1
Sly1969 Sly1969 5 months ago
Article pertinent to TCBP regarding AML treatment that mentions TCBP at the end.https://www.barchart.com/story/news/21369384/why-the-relapsedrefractory-acute-myeloid-leukemia-market-is-expected-to-witness-revolutionary-developments
๐Ÿ‘๏ธ0
Sly1969 Sly1969 5 months ago
Ceo interview on podcast
๐Ÿ‘๏ธ0
resx18 resx18 5 months ago
Big Boys in control #WeHaveThePower $TCBP
👍️ 1 🖕 1
resx18 resx18 5 months ago
#WeHaveThePower $TCBP
🍻 1 🚀 1
resx18 resx18 5 months ago
SONIC BOOM >> $TCBP
👍️ 1
resx18 resx18 5 months ago
Our team is looking forward to the continued clinical and platform expansions in 2024, and anticipate multiple milestone achievements in the next 12 months for investors
👍️ 1
resx18 resx18 5 months ago
"We feel that Excellos is an ideal partner for TCBP, sharing our entrepreneurial spirit and belief in a collaborative effort to advance cell therapies globally," commented CEO Bryan Kobel. "We believe this step materially strengthens our ability to deliver on multiple clinical fronts and creates economic efficiencies within our production planning, while also maintaining our manufacturing autonomy for the final product. Our team is looking forward to the continued clinical and platform expansions in 2024, and anticipate multiple milestone achievements in the next 12 months for investors."
๐Ÿ‘๏ธ0
resx18 resx18 5 months ago
Nice Day here $TCBP
๐Ÿ‘๏ธ0
resx18 resx18 5 months ago
Good Morning $TCBP
๐Ÿ‘๏ธ0
resx18 resx18 5 months ago
Strong volume .. tons of loading. $TCBP
👍️ 1
resx18 resx18 5 months ago
Nice consolidation today $TCBP will fly into next week and beyond!! #LongAndStrong
👍️ 1 🤘 1
resx18 resx18 5 months ago
Good Morning $TCBP
๐Ÿ‘๏ธ0
resx18 resx18 5 months ago
. $TCBP .
🍻 1 👍️ 1
resx18 resx18 5 months ago
Nice Volume $TCBP
๐Ÿ‘๏ธ0
resx18 resx18 5 months ago
$TCBP green on news!
๐Ÿ‘๏ธ0

Your Recent History

Delayed Upgrade Clock